The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines

by Barda, N., Dagan, N.
Published 2022

Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia

by Auclair, D., Ferrari, F., Fischer, E.S, Ghobrial, I.M, Hamilton, M., Horowitz, E., Justis, A.V, Konishi, Y., Lightbody, E.D, Marinac, C.R, Nowak, R.P, Perry, J., Prescott, J., Redd, R.A, Russo, M., Savell, A., Shayegh, N.A, Sklavenitis-Pistofidis, R., Trippa, L., Varmeh, S., Yue, H.
Published 2022

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

by Ayouni, K., Ben Mustapha, I., Ghedira, K., Haddad-Boubaker, S., Kharrat, M., Lakhal, M., Othman, H., Touati, R., Triki, H.
Published 2021

Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice

by Chang, T.-Y, Chen, C.-C, Chen, X.-A, Chiao, D.-J, Kuo, S.-C, Lin, H.-T, Young, J.-J
Published 2021

A proposed workflow for proactive virus surveillance and prediction of variants for vaccine design

by Baker, J.J, Mathy, C.J.P, Schaletzky, J.
Published 2021

Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization

by Ainslie, K.E.C, Klinkenberg, D., Leung, K.Y, Miura, F., Wallinga, J.
Published 2021

Development of new vaccine target against SARS-CoV2 using envelope (E) protein: An evolutionary, molecular modeling and docking based study

by Banerjee, A., Bhattacharya, S., Ray, S.
Published 2021

Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development

by Gruca, A., Grynberg, M., Jarnot, P., Sarnowska, E., Sarnowski, T.J, Ziemska-Legiecka, J.
Published 2021

Advances in clinical outcomes: What we have learned during the COVID-19 pandemic

by Al-Musa, A., Chou, J., Habiballah, S., LaBere, B., Nguyen, A.A
Published 2022

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP

by Al-Samkari, H., Beltrami-Moreira, M., Bussel, J.B, Cines, D.B, Cuker, A., DiRaimo, J., Gernsheimer, T., Kessler, C., Kruse, A., Kruse, C., Kuter, D.J, Leavitt, A.D, Lee, A.I, Lee, E.-J, Liebman, H.A, Newland, A.C, Ray, A.E, Tarantino, M.D, Thachil, J.
Published 2022

Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters

by Kyttaris, V.C, Magliulo, D., Wade, S.D
Published 2022

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19

by Chang, A., Yu, J.
Published 2022